Visualizing diastolic failure: Non-invasive imaging-biomarkers in patients with heart failure with preserved ejection fraction

被引:14
|
作者
Schulz, Alexander [1 ]
Schuster, Andreas [1 ,2 ]
机构
[1] Georg August Univ, Univ Med Ctr Gottingen, Dept Cardiol & Pneumol, D-37099 Gottingen, Germany
[2] Georg August Univ, Univ Med Ctr, Dept Cardiol & Pneumol, Robert Koch Str 40, D-37099 Gottingen, Germany
来源
EBIOMEDICINE | 2022年 / 86卷
关键词
HFpEF; Diastolic dysfunction; Non-invasive imaging; Imaging markers; CARDIOVASCULAR MAGNETIC-RESONANCE; CORONARY MICROVASCULAR DYSFUNCTION; IMPAIRED SYSTOLIC FUNCTION; PULSE-WAVE VELOCITY; ATRIAL-FIBRILLATION; MYOCARDIAL EDEMA; VENTRICULAR ENERGETICS; EXERCISE; FLOW; CARDIOMYOPATHY;
D O I
10.1016/j.ebiom.2022.104369
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heart failure with preserved ejection fraction is an increasing challenge for modern day medicine and has been drawing more attention recently. Invasive right heart catheterization represents the mainstay for the diagnosis of diastolic dysfunction, however due to its attributable risk of an invasive procedure, other non-invasive clinical pathways are trying to approach this pathology in clinical practice. Diastolic failure is complex, and imaging is based on various parameters. In addition to transthoracic echocardiography, numerous novel imaging approaches, such as cardiac magnetic resonance imaging, computed tomography, positron emission (computed) tomography or single photon emission computed tomography techniques are being used to supplement deeper insights into causal pathology and might open targets for dedicated therapy options. This article provides insights into these sophisticated imaging techniques, their incremental value for the diagnosis of this poorly understood disease and recent promising results for an enhanced prognostication of outcome and therapy monitoring. Copyright (c) 2022 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Non-invasive imaging in acute decompensated heart failure with preserved ejection fraction
    Dhont, Sebastiaan
    Verbrugge, Frederik H.
    Verwerft, Jan
    Bertrand, Philippe B.
    EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2024, 13 (07) : 575 - 582
  • [2] Non-Invasive Hemodynamic Assessment of Heart Failure With Preserved Ejection Fraction
    Istratoaie, Sabina
    Frost, Charlotte L.
    Donal, Erwan
    KOREAN CIRCULATION JOURNAL, 2025, 55 (03) : 165 - 184
  • [3] Heart failure with preserved ejection fraction: Is this diastolic heart failure?
    Zile, MR
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (09) : 1519 - 1522
  • [4] Heart failure with preserved ejection fraction (diastolic heart failure)
    Güder G.
    Ertl G.
    MMW - Fortschritte der Medizin, 2019, 161 (9) : 58 - 65
  • [5] The treatment of heart failure with preserved ejection fraction (“diastolic heart failure”)
    Karen Hogg
    John McMurray
    Heart Failure Reviews, 2006, 11 : 141 - 146
  • [6] Diastolic heart failure. Heart failure with preserved ejection fraction
    Dovjak, P.
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2013, 46 (01): : 71 - 81
  • [7] The treatment of heart failure with preserved ejection fraction ("diastolic heart failure")
    Hogg, Karen
    McMurray, John
    HEART FAILURE REVIEWS, 2006, 11 (02) : 141 - 146
  • [8] Biomarkers in heart failure with preserved ejection fraction
    W. C. Meijers
    A. R. van der Velde
    R. A. de Boer
    Netherlands Heart Journal, 2016, 24 : 252 - 258
  • [9] Biomarkers in heart failure with preserved ejection fraction
    Meijers, W. C.
    van der Velde, A. R.
    de Boer, R. A.
    NETHERLANDS HEART JOURNAL, 2016, 24 (04) : 252 - 258
  • [10] Biomarkers in Heart Failure with Preserved Ejection Fraction
    Bayes-Genis, Antoni
    Cediel, German
    Domingo, Mar
    Codina, Pau
    Santiago, Evelyn
    Lupon, Josep
    CARDIAC FAILURE REVIEW, 2022, 8